Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - February 2013


7th Annual Improving Solubility Conference

26 Feb 2013 - 28 Feb 2013 - Philadelphia, PA, USA



Bookmark and Share


IQPC’s Improving Solubility Conference has become an annual meeting for the scientific community. This year, we will showcase the newest solubility technologies and provide the latest research from established industry leaders in order to provide you with practical, applicable knowledge to effectively improve bioavailability and drug candidate solubility.

The competition in the pharmaceutical market is at an all time high and without solid techniques to drive increased bioavailability of your products, you will be left in the dust. Learn the latest methodologies and technologies to take on this challenge and minimize the time-to-market on your drug pipeline.

Gain access to exclusive case studies on:

•    Approaches to Leverage In-Vitro Data to Hypothesize In-Vivo Data
•    Rational Formulation Design Guided by Biopharmaceutics Modeling and Automated Formulation Screening
•    Designing and Developing Super Saturation Based Drugs
•    Enhancing the In-Vivo Performance Hot-Melt Extrusion
•    Introducing Levitation Technology for the Production of Amorphous Drugs
•    Co-Crystal Development: From Mortar & Pestle to Production
•    Influence of Particle Size on the Ultraviolet Spectrum of Particulate-Containing Solutions
•    Stability Prediction for Amorphous Materials



Further information
Scientific News
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
UTSW Researchers Identifies How Drugs Alter Pancreatic Cancer Cells
The findings were published in Cell Reports.
Researchers Identify Process that Causes Chronic Neonatal Lung Disease
Study determines how the NLRP3 inflammasome activates the protein Interleukin 1 beta.
Dengue Vaccine Enters Phase 3 Trial
Investigational vaccine to prevent ‘breakbone fever’ developed at NIH.
Trying to Conceive Soon After a Pregnancy Loss May Increase Chances of Live Birth
NIH study finds no reason for delaying pregnancy attempts after a loss without complications.
BRCA1 Deficiency Increases the Sensitivity of Ovarian Cancer Cells to Auranofin
An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study suggests.
Shingles Vaccine Helps Protect Older Patients with End-stage Renal Disease
Kaiser Permanente study advances knowledge about safety and effectiveness of vaccine commonly given to older adults.
AMRI Acquires Whitehouse Laboratories
Strategically extends AMRI's analytical offerings in rapidly expanding area of outsourcing services.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!